Evidence map›Paper›PMID 31143236›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2019

Determination of antimicotic susceptibility pattern of

Mitra Barati, Shiva Mirkalantari, Saham Ansari, Samira Salari, Azam Fattahi

Abstract read
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mitra BaratiResearch Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
Shiva MirkalantariDepartment of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Saham AnsariDepartment of Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Scienses, Tehran, Iran.
Samira SalariStudent Research Committee, Kerman University of Medical Sciences, Kerman, Iran.
Azam FattahiCenter for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present study was conducted to determine antimicotic susceptibility of MATERIALS AND

methodsIdentification of

resultsThe results from susceptibility test reveal that caspofungin and amphotericin B have high antifungal activity against both albicans (100% and 96%, respectively) and nonalbicans (95.11% and 72.72%, respectively) isolates.

conclusionThe present study suggests that caspofungin and amphotericin B have the excellent ability to eradicate both

Indexed as

Antifungal drugsCandida speciespolymerase chain reaction-restriction fragment length polymorphismsymptomatic candiduria

Identifiers

PMID31143236
PMCPMC6521611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.